Global Clinical Trial Supply & Logistics Market Report 2023: Expansion of Clinical Trial Sites Drives Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global clinical trials supply & logistics market is expected to reach USD 6.3 billion by 2030, expanding at a CAGR of 7.5% from 2023 to 2030.

Companies Mentioned

• Thermo Fisher Scientific (Patheon)
• Catalent, Inc.
• Parexel
• Almac Group
• Marken
• Piramal Pharma Solutions
• UDG Healthcare
• DHL
• FedEx
• Movianto
• Packaging Coordinators Inc.

The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.

Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus.

However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.

There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management.

The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.

Clinical Trials Supply & Logistics Market Report Highlights

• In service segment, logistics & distribution dominated the market in 2022 with a share of 25.3%. This is due to the rise in clinical trials due to COVID- 19 pandemic
• Based on phase, phase III segment dominated the market with a market share of 43.4% in 2022
• Based on therapeutic area, cardiovascular diseases accounted for the fastest CAGR of 8.0% during the forecast period. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market
• Asia Pacific is anticipated to register the fastest growth rate of 8.1% during the forecast period. This is due to low recruitment cost, region has access to a large and diversified patient pool, and favorable policies that make the region desirable for clinical trials

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Clinical Trial Supply & Logistics Market Variables, Trends & Scope

3.1 Market Dynamics

3.1.1 Market Driver Analysis

3.1.1.1 Technological advancements in supply chain

3.1.1.2 Increasing R&D investment by pharmaceutical and biopharmaceutical firms

3.1.1.3 Expansion of clinical trial sites

3.1.2 Market Restraint Analysis

3.1.2.1 Stringent regulation pertaining to logistics

3.1.2.2 Counterfeiting of drugs

3.1.3 SWOT Analysis by PESTEL

3.1.4 Industry Analysis - Porter's

3.1.5 Clinical Trial Supply & Logistics Market: Impact of COVID - 19

Chapter 4 Clinical Trial Supply & Logistics Market: Segment Analysis, By Service, 2018 - 2030 (USD Million)

Chapter 5 Clinical Trial Supply & Logistics Market: Segment Analysis, By Phase, 2018 - 2030 (USD Million)

Chapter 6 Clinical Trial Supply & Logistics Market: Segment Analysis, By End-User, 2018 - 2030 (USD Million)

Chapter 7 Clinical Trial Supply & Logistics Market: Segment Analysis, By Therapeutic Areas, 2018 - 2030 (USD Million)

Chapter 8 Clinical Trials Supply & Logistics Market: Regional Estimates And Trend Analysis, By Service, Phase, End - User, & Therapeutic Area

Chapter 9 Competitive Landscape

9.1 Company Market Share

9.1.1 Company market share analysis (2022)

Chapter 10 Competitive Landscape

10.1 Participants' Overview

10.2 Financial Performance

10.3 Strategy Initiatives

10.3.1 Acquisition

10.3.2 Collaboration/ Partnerships

10.3.3 Expansion

10.3.4 Product Launch

10.3.5 Others

For more information about this report visit https://www.researchandmarkets.com/r/1lzc7l

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900